A Portable and Scalable Genomic Analysis Pipeline for Streptococcus pneumoniae Surveillance: GPS Pipeline
Harry C. H. HungiD, Narender KumariD, Victoria R. CarriD, Corin YeatsiD, Benjamin J. MetcalfiD, Yuan LiiD, Paulina A. HawkinsiD, Lesley McGeeiD, Stephen D. BentleyiD, Stephanie W. LoiD
Abstract
Ever increasing global sequencing capacity provides an unprecedented opportunity in utilising genomic information captured from whole-genome sequencing to enhance pathogen surveillance. However, there is a growing need for developing user-friendly tools to effectively analyse the increasing volume of data. To meet this need, we have developed a genomic analysis pipeline, GPS Pipeline, which is portable and scalable to analyse genomes of Streptococcus pneumoniae, a major bacterial pathogen that is estimated to cause 317,000 child deaths worldwide every year. The GPS Pipeline is based on Nextflow and containerisation technology, and designed to enable researchers generating public health relevant output, including in silico serotypes, pneumococcal lineages (i.e. GPSCs), multilocus sequence types, and antimicrobial susceptibilities against 20 commonly used antibiotics,with minimal software setup requirements and bioinformatic expertise, in order to analyse genomic data at scale with ease. The GPS Pipeline provides a streamlined workflow that improves responsiveness in genomic surveillance on pneumococci. Data SummaryThe GPS Pipeline is available on GitHub at github.com/GlobalPneumoSeq/gps-pipeline. Published data from the GPS Database is available on Monocle Data Viewer at data.monocle.sanger.ac.uk and associated sequence read files are searchable and downloadable in the European Nucleotide Archive at ebi.ac.uk/ena via their ERR accession numbers. Impact StatementThe GPS Pipeline advances global genomic surveillance of Streptococcus pneumoniae by providing a scalable, portable, and user-friendly tool for analysing whole-genome sequencing data. Leveraging Nextflow and containerisation technology, it minimises bioinformatics expertise requirements and infrastructure needs, making it particularly valuable in low- and middle-income countries where pneumococcal disease burden is high. This pipeline ensures reproducibility and stability across platforms, facilitating rapid and accurate pneumococci genomic analysis. By streamlining data processing, the GPS Pipeline enhances pathogen surveillance, generates evidence to support vaccine strategy development, and empowers researchers worldwide, ultimately contributing to improved public health outcomes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 13
- FWCI
- 8.93
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Graph-based Nanopore Adaptive Sampling with GNASTy enables sensitive pneumococcal serotyping in complex samples
Samuel Horsfield, Basil C.T. Fok, … Nicholas J. Croucher·bioRxiv·Feb 11, 2024
- PfaSTer: A ML-powered serotype caller for Streptococcus pneumoniae genomes
Jonathan T. Lee, Xingpeng Li, … Hao Li·bioRxiv·Nov 30, 2022
- SeroBA: rapid high-throughput serotyping of Streptococcus pneumoniae from whole genome sequence data
Lennard Epping, Andries J. van Tonder, … Jacqueline A. Keane·Microbial GenomicsPeer-reviewed·Jun 5, 2018
- PathogenSurveillance: an automated pipeline for population genomic analyses and pathogen identification
Zachary Foster, Martha A. Sudermann, … Niklaus J. Grünwald·bioRxiv·Oct 31, 2025
- Evidence of virulence and antimicrobial resistance in Streptococcus pneumoniae serotype 16F lineages
Jolynne Mokaya, Kate C. Mellor, … Felix Sizwe Dube·bioRxiv·Aug 25, 2023
- Pneumo-Typer: integrated genomic surveillance tool for capsule genotype, serotype and sequence type in Streptococcus pneumoniae informs vaccine strategies
Xiangyang Li, Haitao Zhang, … Zhongrui Ma·bioRxiv·Feb 13, 2025